Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc (JAZZ)

Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
247. 53
+5.35
+2.2091%
$
14.95B Market Cap
17.91 P/E Ratio
- Div Yield
503,600 Volume
18.96 Eps
$ 242.18
Previous Close
Add Transaction
Day Range
238.08 249.5
Year Range
105 250.49
Want to track JAZZ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock

Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 week ago
Jazz Pharmaceuticals (JAZZ) Price Forecast: Will Breakout Confirm Higher Highs?

Jazz Pharmaceuticals (JAZZ) Price Forecast: Will Breakout Confirm Higher Highs?

Jazz Pharmaceuticals is testing a bull flag breakout following a long-term base advance, with confirmation needed above key swing resistance to validate continuation toward new highs.

Fxempire | 2 weeks ago
Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Momentum Stock: Should You Buy?

Jazz Pharmaceuticals (JAZZ) is a Top-Ranked Momentum Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 2 weeks ago
JAZZ & ABCL Team Up to Develop Next-Generation Solid Tumor Therapies

JAZZ & ABCL Team Up to Develop Next-Generation Solid Tumor Therapies

Jazz Pharmaceuticals teams up with AbCellera to discover and develop T-cell-engaging antibodies for GI cancers and other solid tumors.

Zacks | 1 month ago
JAZZ's Zepzelca Fails to Meet Primary Goal in Lung Cancer Study

JAZZ's Zepzelca Fails to Meet Primary Goal in Lung Cancer Study

Jazz Pharmaceuticals' Zepzelca fails a phase III lung cancer study, but strong first-line uptake and 2026 guidance remain unchanged.

Zacks | 1 month ago
Jazz Pharmaceuticals lung cancer drug fails main trial goal

Jazz Pharmaceuticals lung cancer drug fails main trial goal

Jazz Pharmaceuticals said on Friday its lung cancer drug Zepzelca ​failed to meet the main goal of ‌improving overall survival in a late-stage study, potentially risking its current regulatory status.

Reuters | 1 month ago
Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term

Why Jazz Pharmaceuticals (JAZZ) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 month ago
Why Is Jazz (JAZZ) Up 1% Since Last Earnings Report?

Why Is Jazz (JAZZ) Up 1% Since Last Earnings Report?

Jazz (JAZZ) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 month ago
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Momentum Stock

Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 month ago
Jazz Pharmaceuticals plc (JAZZ) Presents at TD Cowen's 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA Transcript

Jazz Pharmaceuticals plc (JAZZ) Presents at TD Cowen's 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA Transcript

Jazz Pharmaceuticals plc (JAZZ) Presents at TD Cowen's 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA Transcript

Seekingalpha | 1 month ago
Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock

Here's Why Jazz Pharmaceuticals (JAZZ) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 month ago
Jazz Pharmaceuticals plc (JAZZ) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Jazz Pharmaceuticals plc (JAZZ) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Jazz Pharmaceuticals plc (JAZZ) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript

Seekingalpha | 2 months ago
Loading...
Load More